Skip to content

Insider · CIK 0001108683

Robert Greene Sterne

director

Files at PRKR (PARKERVISION INC). First filing -, latest -.

Robert Greene Sterne files SEC Form 4 as director at PRKR (PARKERVISION INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Robert Greene Sterne has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 22, 2026PRKR
PARKERVISION INC
AGrant or award
Option to Purchase Common Stockderivative
+370,000$0.24$89k370,000Jan 26, 2026
Jul 3, 2025PRKR
PARKERVISION INC
AGrant or award
Option to Purchase Common Stockderivative
+300,000$0.29$87k300,000Jul 8, 2025

Questions about Robert Greene Sterne

Answered from the filings on this page, as of the latest one.

Is Robert Greene Sterne buying or selling?

Robert Greene Sterne has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Robert Greene Sterne's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Greene Sterne has 0.

Where does Robert Greene Sterne file Form 4?

Robert Greene Sterne has filed Form 4 at PRKR (PARKERVISION INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.